Literature DB >> 9921911

Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization.

Y Zhang1, P Matthiesen, R Siebert, S Harder, M Theile, S Scherneck, B Schlegelberger.   

Abstract

Dual-color fluorescence in situ hybridization was performed to detect the frequency and extent of 6q deletions in ten breast carcinoma cell lines. In five cell lines, the 6q deletions involved large regions extending from 6q12-q16 to 6q27, and in one the deletion extended from the region distal to YAC 751G10 at 6q25.1 to 6q27. In two cell lines, 6q deletions occurred only in cells with polysomy 6, indicating that such deletions might be secondary chromosomal aberrations and reflect late genetic changes in breast carcinomas. In addition, an overrepresentation of 6q21-q22.2 was detected in one cell line.

Entities:  

Mesh:

Year:  1998        PMID: 9921911     DOI: 10.1007/s004390050899

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  3 in total

1.  The putative tumor suppressor Zc3h12d modulates toll-like receptor signaling in macrophages.

Authors:  Shengping Huang; Dongfei Qi; Jian Liang; Ruidong Miao; Kentaro Minagawa; Tim Quinn; Toshimitsu Matsui; Daping Fan; Jianguo Liu; Mingui Fu
Journal:  Cell Signal       Date:  2011-10-20       Impact factor: 4.315

2.  Implication of snoRNA U50 in human breast cancer.

Authors:  Xue-Yuan Dong; Peng Guo; Jeff Boyd; Xiaodong Sun; Qunna Li; Wei Zhou; Jin-Tang Dong
Journal:  J Genet Genomics       Date:  2009-08       Impact factor: 4.275

3.  6q deletion is frequent but unrelated to patient prognosis in breast cancer.

Authors:  Patrick Lebok; Hannah Bönte; Martina Kluth; Christina Möller-Koop; Isabell Witzel; Linn Wölber; Peter Paluchowski; Christian Wilke; Uwe Heilenkötter; Volkmar Müller; Barbara Schmalfeldt; Ronald Simon; Guido Sauter; Luigi Terracciano; Rainer Horst Krech; Albert von der Assen; Eike Burandt
Journal:  Breast Cancer       Date:  2021-10-08       Impact factor: 4.239

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.